Tag: Gain Therapeutics Inc.

Company

What To Expect As Gain Therapeutics Inc (NASDAQ: GANX) Delivers An 6.63% Loss In 6 Months

During the last session, Gain Therapeutics Inc (NASDAQ:GANX)’s traded shares were 0.77 million, with the beta value of the company hitting 0.11. At the end

Science

Gain Therapeutics Inc (NASDAQ:GANX) Has Recovered -14.10% To Date, But An Additional -58.71% Is Possible.

In last trading session, Gain Therapeutics Inc (NASDAQ:GANX) saw 0.47 million shares changing hands with its beta currently measuring 0.12. Company’s recent per share price

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: Gain Therapeutics Inc.

What To Expect As Gain Therapeutics Inc (NASDAQ: GANX) Delivers An 6.63% Loss In 6 Months

Gain Therapeutics Inc (NASDAQ:GANX) Has Recovered -14.10% To Date, But An Additional -58.71% Is Possible.

Quick Links

Categories